نتایج جستجو برای: phenylalanine hydroxylase pah deficiency

تعداد نتایج: 172799  

Journal: :Human mutation 2007
Charles R Scriver

"Inborn errors of metabolism," first recognized 100 years ago by Garrod, were seen as transforming evidence for chemical and biological individuality. Phenylketonuria (PKU), a Mendelian autosomal recessive phenotype, was identified in 1934 by Asbjörn Fölling. It is a disease with impaired postnatal cognitive development resulting from a neurotoxic effect of hyperphenylalaninemia (HPA). Its meta...

Journal: :Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 1977

Journal: :iranian journal of basic medical sciences 0
morteza bagheri food and beverages safety research center, urmia university of medical sciences, urmia, iran genetics department, urmia university of medical sciences, urmia, iran cellular and molecular research center, urmia university of medical sciences, urmia, iran isa abdi rad food and beverages safety research center, urmia university of medical sciences, urmia, iran genetics department, urmia university of medical sciences, urmia, iran cellular and molecular research center, urmia university of medical sciences, urmia, iran

objective(s):phenylketonuria (pku) is a genetic inborn error of phenylalanine (phe) metabolism resulting from insufficiency in the hepatic enzyme, phenylalanine hydroxylase (pah), which leads to elevated levels of phe in the blood. the present study was carried out for mutation analysis of the pah gene in west azerbaijan province of iran. materials and methods:a total of 218 alleles from 40 pku...

2014
Olaoluwa Okusaga Olesja Muravitskaja Dietmar Fuchs Ayesha Ashraf Sarah Hinman Ina Giegling Annette M. Hartmann Bettina Konte Marion Friedl Jason Schiffman Elliot Hong Gloria Reeves Maureen Groer Robert Dantzer Dan Rujescu Teodor T. Postolache

BACKGROUND Phenylalanine and tyrosine are precursor amino acids required for the synthesis of dopamine, the main neurotransmitter implicated in the neurobiology of schizophrenia. Inflammation, increasingly implicated in schizophrenia, can impair the function of the enzyme Phenylalanine hydroxylase (PAH; which catalyzes the conversion of phenylalanine to tyrosine) and thus lead to elevated pheny...

2010
Nenad Blau

10.1586/EEM.10.39 Phenylketonuria Phenylketonuria (PKU; Online Mendelian Inheritance in Man No. 262600) is a genetic disorder characterized by a deficiency of the hepatic enzyme phenylalanine-4-hydroxylase (PAH; EC 1.14.16.1), causing elevated concentrations of phenylalanine (Phe) in the blood and brain. Hyperphenylalaninemia (HPA) can also be caused by a deficiency of tetrahydrobiopterin (BH4)...

2007
MAJA STOJILJKOVIĆ ANA STEVANOVIĆ MAJA DJORDJEVIĆ BRANKA PETRUČEV NATAŠA TOŠIĆ TEODORA KARAN DJURAŠEVIĆ SANJA AVEIĆ MILENA RADMILOVIĆ SONJA PAVLOVIĆ

Phenylketonuria (PKU), an inborn error of metabolism, is caused by mutations in the phenylalanine hydroxylase (PAH) gene. In the Serbian population, 19 different PAH mutations have been identified. We used PAH mutations as molecular markers for population genetics study. The low homozygosity value of the PAH gene (0.10) indicates that PKU in Serbia is heterogeneous, reflecting numerous migratio...

Journal: :The international journal of neuropsychopharmacology 2009
Tiziana Pascucci Diego Andolina Immacolata La Mela David Conversi Claudio Latagliata Rossella Ventura Stefano Puglisi-Allegra Simona Cabib

Adult early treated hyperphenylalaninaemic patients can show specific deficits of prefrontal cortical functions. The development of additional therapeutic strategies for these patients requires the understanding of the mechanisms involved in phenylalanine-dependent impairment of fronto-cortical functions. We tested the hypothesis of phenylalanine interference with aminergic neurotransmission in...

Journal: :Human molecular genetics 2010
Søren W Gersting Florian B Lagler Anna Eichinger Kristina F Kemter Marta K Danecka Dunja D Messing Michael Staudigl Katharina A Domdey Clemens Zsifkovits Ralph Fingerhut Hartmut Glossmann Adelbert A Roscher Ania C Muntau

The recent approval of sapropterin dihydrochloride, the synthetic form of 6[R]-l-erythro-5,6,7,8-tetrahydrobiopterin (BH(4)), for the treatment of phenylketonuria (PKU) as the first pharmacological chaperone drug initiated a paradigm change in the treatment of monogenetic diseases. Symptomatic treatment is now replaced by a causal pharmacological therapy correcting misfolding of the defective p...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید